Skip to content

BODISEN BIOTECH, INC

Delisted

CIK 1178552fmd_0TNB7W84QDR87ZSMV4J56JCKCEManufacturing · Agricultural ChemicalsTemplate: Standard

Coverage: Jan 01, 2010 to Jun 30, 2013, 12 periods

Income Statement · Annual · Millions · USD
Line itemFY2010FY2011FY2012
Cost of revenue667
Gross profit121
Research and development––3
Total operating expenses5415
Operating income(4)(2)(14)
Interest expense000
Interest and investment income000
Other non-operating income (expense)(0)(0)(3)
Net income(4)(2)(16)